Thursday, August 10, 2017

Price control does not stifle innovation


"on the grounds that it was harmful to innovation" 
This is the most absurd of excuses, just look at all the un-executed patents and other intellectual property that corporations have quashed to limit competition. Price controls do not prevent scientists from developing/designing new drugs; they're excuses for pharma to not transfer new treatments from innovators to markets. The middlemen don't want to sell it because they make less profit. 
If the roadblock is big pharma, would it be possible to establish an alternate route to market drugs? Maybe it's time for real competition to enter the pharmaceutical industry.

No comments:

Post a Comment